METROPOLITAN LIFE INSURANCE CO/NY - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 55 filers reported holding CASI PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$76,163
-12.2%
18,946
+1.9%
0.00%0.0%
Q3 2018$86,792
-99.9%
18,5850.0%0.00%0.0%
Q2 2018$152,954,00018,5850.00%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
IDG-Accel China Growth Fund III Associates L.P. 7,973,536$12,359,00022.48%
Consonance Capital Management LP 10,321,956$15,999,0001.92%
Wellington Shields & Co., LLC 1,832,769$2,841,0000.94%
Wellington Shields Capital Management, LLC 2,258,264$3,500,0000.42%
Ghost Tree Capital, LLC 650,000$1,008,0000.28%
Ikarian Capital, LLC 1,268,154$1,966,0000.16%
Tibra Equities Europe Ltd 216,300$335,0000.10%
1492 Capital Management LLC 79,743$124,0000.06%
Sterneck Capital Management, LLC 40,000$47,0000.03%
FEDERATED HERMES, INC. 10,150,000$15,733,0000.03%
View complete list of CASI PHARMACEUTICALS INC shareholders